Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-22T08:38:53.122Z Has data issue: false hasContentIssue false

DULOXETINE

Published online by Cambridge University Press:  03 April 2024

Stephen M. Stahl
Affiliation:
University of California, San Diego and Riverside
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Prescriber's Guide
Stahl's Essential Psychopharmacology
, pp. 277 - 282
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Arnold, LM, Pritchett, YL, D’Souza, DN, et al. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled trials. J Womens Health (Larchmt) 2007;16(8):1145–56.CrossRefGoogle Scholar
Bymaster, FP, Dreshfield-Ahmad, LJ, Threlkeld, PG, et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001;25(6):871–80.CrossRefGoogle ScholarPubMed
Hartford, J, Kornstein, S, Liebowitz, M, et al. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from placebo and active-controlled trial. Int Clin Psychopharmacol 2007;22(3):167–74.CrossRefGoogle ScholarPubMed
Muller, N, Schennach, R, Riedel, M, Moller, HJ. Duloxetine in the treatment of major psychiatric and neuropathic disorders. Expert Rev Neurother 2008;8(4):527–36.CrossRefGoogle ScholarPubMed
Zinner, NR. Duloxetine: a serotonin–noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence. Expert Opin Investig Drugs 2003;12(9):1559–66.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • DULOXETINE
  • Stephen M. Stahl, University of California, San Diego and Riverside
  • Book: Prescriber's Guide
  • Online publication: 03 April 2024
  • Chapter DOI: https://doi.org/10.1017/9781009464772.046
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • DULOXETINE
  • Stephen M. Stahl, University of California, San Diego and Riverside
  • Book: Prescriber's Guide
  • Online publication: 03 April 2024
  • Chapter DOI: https://doi.org/10.1017/9781009464772.046
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • DULOXETINE
  • Stephen M. Stahl, University of California, San Diego and Riverside
  • Book: Prescriber's Guide
  • Online publication: 03 April 2024
  • Chapter DOI: https://doi.org/10.1017/9781009464772.046
Available formats
×